Zeon Lifesciences Strengthens U.S. Market Readiness with FDA Registration

Indian nutraceutical manufacturer Zeon Lifesciences has bolstered its readiness for the U.S. market by registering its facility with the U.S. Food and Drug Administration (FDA). The company has also successfully passed inspections by U.S. FDA officials under the Food Safety Modernization Act (FSMA).

This FDA registration and successful clearance of inspections are critical steps for Zeon Lifesciences as it expands into the North American market. Access to the U.S. market requires adherence to stringent regulations, and these actions demonstrate the company's commitment to international quality and safety standards.

Additionally, the company has obtained global quality certifications, supporting its international market ambitions. These certifications validate the quality and safety of Zeon Lifesciences' production processes and products.

Zeon Lifesciences focuses on the manufacturing of nutraceuticals, aiming to promote health and wellness through its products. The FDA registration and global certifications represent strategic moves toward achieving the company's growth objectives.